Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 18;14(4):616-621.
doi: 10.18240/ijo.2021.04.20. eCollection 2021.

Ocular surface changes in Graves' ophthalmopathy

Rou Sun  1   2 , Hui-Fang Zhou  1   2 , Xian-Qun Fan  1   2
Affiliations
Review

Ocular surface changes in Graves' ophthalmopathy

Rou Sun et al. Int J Ophthalmol. .

Abstract

Many patients with Graves' ophthalmopathy (GO) suffer from dry eye syndrome (DES), and this is one of the most common reasons of eye discomfort in patients with GO. The prevalence of DES in patients with GO is significantly higher than normal subjects. The ocular surface changes involving changes in tears, cornea, conjunctiva and glands occur in GO patients. However, the mechanism of how DES occurs in GO still remains unclear. In this review, the ocular surface changes were illustrated and analyzed the reasons for high prevalence of DES in GO patients.

Keywords: Graves' ophthalmopathy; dry eye syndrome; ocular surface.

PubMed Disclaimer

References

    1. Smith TJ, Hegedüs L. Graves' disease. N Engl J Med. 2016;375(16):1552–1565. - PubMed
    1. Wang Y, Smith TJ. Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci. 2014;55(3):1735–1748. - PMC - PubMed
    1. Smith TJ. Challenges in orphan drug development: identification of effective therapy for thyroid-associated ophthalmopathy. Annu Rev Pharmacol Toxicol. 2019;59:129–148. - PMC - PubMed
    1. Mohyi M, Smith TJ. IGF1 receptor and thyroid-associated ophthalmopathy. J Mol Endocrinol. 2018;61(1):T29–T43. - PMC - PubMed
    1. Smith TJ, Janssen JA. Building the case for insulin-like growth factor receptor-I involvement in thyroid-associated ophthalmopathy. Front Endocrinol (Lausanne) 2016;7:167. - PMC - PubMed

LinkOut - more resources